Keywords
Pathogenesis
Drug therapy
Submitted : 2024-07-13
Accepted : 2024-07-28
Published : 2024-08-12
Abstract
Diabetic cataract (DC) is a common complication prior to diabetes mellitus, which is a metabolic disease with pathogenesis including abnormal metabolism of polyphenol pathway (PP) and non-enzymatic glycosylation (NEG) of proteins, etc. The therapeutic drugs are mainly aldose reductase inhibitors (ARIs) and glycosylation inhibitors. The therapeutic regimens for DC are becoming more and more diversified due to the development of biological testing and clinical research technology, thus improving its clinical efficacy. With the development of biological testing and clinical research technology, the treatment options for DC have become increasingly diversified and the treatment specificity has been improved, improving its clinical efficacy. In order to comprehensively analyze the pathogenesis and pharmacological treatment of this disease, the following review is made.
References
Gou Q, Li H, 2022, Study on Diabetes-Related Ocular Changes and Complications. Medical Information, 35(18): 153–156.
Li X, Liao J, Huang K, et al., 2023, Application Value of Serum 1,5-AG in Early Diagnosis of Type 2 Diabetes Mellitus. Modern Medicine, 51(9): 1220–1226.
Han Z, Li J, Xu Z, et al., 2023, Design, Synthesis and Activity Evaluation of Multifunctional Aldose Reductase Inhibitors with Novel Quinolone Structure. Chemical Research and Application, 35(3): 691–697.
Ma T, 2021, Effects of Inhibitors of Glycosylation End Products on Diabetic Complications. Medical Information, 34(10): 65–67, 71.
Liu Y, Du S, Shao J, et al., 2020, Expression of Receptor for Advanced Glycosylation End Products (RAGE) in the Anterior Capsule Membrane and Human Lens Epithelial Cells of Patients with Diabetic Cataract and Age-Related Cataract. New Progress in Ophthalmology, 40(11): 1015–1019.
Li Q, Wang G, Chen J, et al., 2023, Effect of Hesperidin Modulation of Keap1/Nrf2/ARE Signaling Pathway on Oxidative Stress Injury in D-Galactose-Induced Cataract Rats. Hebei Medicine, 29(2): 195–200.
Jiang F, Zhu J, Liu Q, et al., 2020, Effects of Aldose Reductase Inhibitors on NLRP3 Inflammasome Expression in Patients with Diabetic Peripheral Neuropathy. Hainan Medicine, 31(21): 2750–2754.
Chen L, 2021, Clinical Study of Aldose Reductase Inhibitor in the Treatment of Diabetic Peripheral Neuropathy. Diabetes World, 18(3): 55.
Wang J, Yuan Y, 2020, Effects of Epalrestat Combined with Taurine on Postoperative Inflammation and Oxidative Stress Factors in Diabetic Cataract Patients. Modern Medicine, 48(5): 602–607.
Zheng J, Zheng Y, Chen F, 2021, Effects of Panax Ginseng Total Saponin Combined with Pimagedine Treatment on Blood CRP, TNF-Alpha, MDA and SOD Levels in Renal Function of Rats with Diabetic Nephropathy. Hebei Medicine, 27(9): 1414–1418.
Han X, Yan Q, Wang X, 2020, Proteomic Analysis of Lysine Acetylation in Mouse Lens Epithelial Cells Under High Glucose Microenvironment. Journal of China Medical University, 49(8): 694–700.
Wu J, Zhao S, Wu W, et al., 2018, Inhibitory Effect of Shiquan Dajian Tang on Spontaneous Tumor of Lens in SV40T Antigen Transgenic Mice and Its Molecular Mechanism. Journal of Jilin University (Medical Edition), 44(1): 5.
Yin L, Yao Y, 2023, Clinical Study of Vitamin A Palmitate Ophthalmic Gel Combined with Diclofosol Sodium Eye Drops for the Treatment of Dry Eye After Cataract Ultrasonic Emulsification. Journal of Nantong University (Medical Edition), 43(2): 137–140.
Liu J, Xu X, Kang W, et al., 2022, Effects of Dandelion Flavonoids on Antioxidant Enzyme Activities and Related Gene Expressions in ICR Mice. Genomics and Applied Biology, 6(1): 41.